Literature DB >> 9628376

Clinical patterns and trends of outcome of elderly patients with bronchogenic carcinoma.

P Thomas1, M Piraux, L F Jacques, J Grégoire, P Bédard, J Deslauriers.   

Abstract

OBJECTIVE: To investigate the clinical characteristics and determinants of operative mortality and long-term survival of elderly patients submitted to pulmonary resection for intended cure of lung cancer.
METHODS: Retrospective analysis of 500 consecutive pulmonary resections performed in patients aged over 70 years from 1975 to 1996. Predictors of in-hospital mortality were identified by univariate and multivariate analyses. Determinants of long-term outcome were investigated in all survivors, with no patient being lost to follow-up.
RESULTS: Mean age was 74 +/- 3 years (maximum: 90), and 36 patients were octogenarians. The sex-ratio M:F was 5:3. History of combined cardiovascular or previous neoplastic disease was noted in 193 and 63 patients, respectively. The predominant histology was squamous cell carcinoma (n = 243), with a significantly higher incidence in male than in female. Most patients received standard procedures, while 103 patients underwent extended resections for tumors involving the mediastinum (n = 44), the chest wall (n = 33), the carina (n = 2) or had a sleeve resection of the main bronchus (n = 24). Procedures were considered to be complete and curative in 459 patients, among whom 294 had a stage I disease. There were 37 (7.4%) in-hospital deaths. Mortality rates following pneumonectomy, bilobectomy, lobectomy and lesser resection were 11:136, 4:34, 22:291, and 0:39, respectively. Age, male gender, hypertension, low FEV1 and extended procedure were identified as independent predictors of early mortality. Overall survival rates were 33.7 and 12% at 5 and 10 years, respectively. Multivariate analysis demonstrated that the disease stage was the main prognosticator. During the follow-up period, cancer recurrence (n = 183; 39.5%) or second primary lung cancer (n = 20; 4.3%) occurred in 203 patients, among whom 18 (9%) had a second lung resection. Carcinoma in other systems occurred in 25 patients (5.3%), and major cardiovascular event in 51 (11%).
CONCLUSIONS: Male and squamous cell carcinoma are characteristic of elderly patients with resected lung cancer. Operative mortality is acceptable for standard resection, and survival figures are concordant with those reported in other series which include younger patients.

Entities:  

Mesh:

Year:  1998        PMID: 9628376     DOI: 10.1016/s1010-7940(98)00011-6

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  6 in total

Review 1.  Lung cancer 7: management of lung cancer in elderly patients.

Authors:  R Booton; M Jones; N Thatcher
Journal:  Thorax       Date:  2003-08       Impact factor: 9.139

Review 2.  Management of elderly patients with lung cancer.

Authors:  M R Ranson; S White; N Thatcher
Journal:  Curr Oncol Rep       Date:  2000-01       Impact factor: 5.075

Review 3.  [Thoracic surgery in the elderly].

Authors:  H Dienemann; H Hoffmann; F Herth
Journal:  Chirurg       Date:  2005-02       Impact factor: 0.955

4.  Impact of mediastinal lymph node dissection on octogenarians with non-small cell lung cancer.

Authors:  Shinjiro Mizuguchi; Kiyotoshi Inoue; Takashi Iwata; Nobuhiro Izumi; Takuma Tsukioka; Ryuhei Morita; Tatsuya Nishida; Noritoshi Nishiyama; Taichi Shuto; Shigefumi Suehiro
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2006-03

Review 5.  Is surgery indicated for elderly patients with early stage nonsmall cell lung cancer, in the era of stereotactic body radiotherapy?

Authors:  Nam P Nguyen; Juan Godinez; Wei Shen; Vincent Vinh-Hung; Helena Gorobets; Juliette Thariat; Fred Ampil; Jacqueline Vock; Ulf Karlsson; Alexander Chi
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

6.  Measurement of mid-arm muscle circumference and prognosis in stage IV non-small cell lung cancer patients.

Authors:  Rafaela Festugatto Tartari; Jane Maria Ulbrich-Kulczynski; Antônio Fabiano Ferreira Filho
Journal:  Oncol Lett       Date:  2013-01-11       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.